Perioperative Medicine is rapidly evolving with changing demographics of patient population, advanced technology, and emerging new concepts in monitoring and management. To date, there have been no exclusive conferences of meetings devoted to the perioperative care of the cancer patient. The importance and immediate need for meetings are reiterated in Institute of Medicine’s report on “Retooling for an Aging America”, the executive summary noted that “In 2011 the first baby boomers will turn 65, ushering in a new generation of older Americans with a significantly higher rate of cancer burden. Older Americans use considerably more health care services than younger Americans and their health care needs are often complex.
Cancer remains a major health problem in the United States. It is estimated that by 2030 the incidence of cancer would increase by 45% largely as a result of the aging baby-boomer population and longer life expectancies. Cancer is currently the second most common cause of death in the United States, exceeded only by heart disease. Cancer accounts for nearly 1 out of every 4 deaths in the United States. In addition, for all cancers combined, people 65 years of older have an incidence rate 10 times greater than the rate for younger people and the mortality rate for older cancer patients is 16 times greater than the rate for younger patients. This therefore, is an emerging “tsunami” that the government and the society have to be prepared to deal with. Our goal is for this program to evolve and mature into a multi-specialty international consortium that will address the educational, research and clinical needs of this emerging demographic.
Furthermore, given the current challenges with run-away costs of health care delivery in the US, this meeting will also focus on effective strategies on delivering value based perioperative care with patient centric focus (minimizing symptom burden, and enhancing functional recovery). The US health care system can benefit immensely if the focus is shifted to building effective teams by standardizing care processes through evidence based interventions, and to anticipate and mitigate risk by rapid rescue with effective and timely interventions. Given the goals of the conference and the need to develop effective teams in healthcare, there will be discussion on the opportunities and challenges to transform health care into a high reliability industry.
- Incorporate the knowledge of cancer epidemiology and biology to improve the perioperative and oncological outcomes for the cancer patient.
- Implement a strategy to deliver patient centric value based perioperative care.
- Utilize the appropriate research methodology in perioperative medicine to improve patient outcomes.
- Discuss the nuts and bolts and the value of implementing Enhanced Recovery programs.
- Discuss and implement strategies to build effective teams in health care and develop quality in perioperative practice.
- Demonstrate various methods of managing patients with airway compromise, hemodynamic issues, and controlling pain with regional anesthesia.
Why MD Anderson?
MD Anderson Cancer Center is one of the largest and most renowned cancer centers in the world. MD Anderson has ranked as one of the top two hospitals in cancer care every year since U.S. News & World Report began its annual “America’s Best Hospitals” survey in 1990. MD Anderson Cancer Center’s workforce is more than 20,000 strong. That includes more than 1,700 faculty members including nine Institute of Medicine members, three National Academy of Sciences members, four Academy of Arts and Sciences fellows and 34 American Association for the Advancement of Science fellows.
In FY 2015, MD Anderson Cancer Center treated more than 135,000 people. More than 9,400 participants were enrolled in clinical trials exploring innovative treatments. It is the nation’s largest cancer clinical trial program. MD Anderson has 81 accredited Graduate Medical Education Programs, and almost 6,600 trainees are enrolled in its educational programs.
MD Anderson Cancer Center’s Moon Shots Program is an unprecedented effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. The program is designed to bring together the best attributes of academia and industry by creating multi-disciplinary teams to convert knowledge into tests, devices, drugs and policies that can benefit patients as quickly as possible. MD Anderson Cancer Center’s GAP (Global Academic Programs) supports MD Anderson’s Sister Institution Network, the largest global network of cancer centers working collaboratively to end cancer.
Our department has a long standing history of excellence in supporting our world class surgical programs. We have over 20 years’ experience in conducting excellent educational programs, and we have the first Fellowship program in Cancer Anesthesia in the country.
- 5 day scientific and educational event
- Scientific abstracts and best of the meeting awards
- International scientific advisory panel
- Lectures, pro-con debates, panel discussions and hands-on workshops
- Welcome reception (11/29/17) and Social event with “Tex Mex Theme” (12/1/17)
MD Anderson Cancer Center Organizing Committee
- Vijaya Gottumukkala, MBBS, MD(Anes), FRCA
- Lori Dangler, MD MBA
- Garry Brydges, DNP, MSN, MBA, ACNP-BC, CRNA
MD Anderson Cancer Center Sponsor
- Thomas Rahlfs, MD
Scientific Advisory & Program Committee
- Bernhard Riedel, MB, ChB, FCA, MMed, PhD
- Donal Buggy, MD, MSc, FRCA
- Johannes M. Huitink, MD, PhD
- Tim Wigmore, MB,BS; FRCA
- Shamgar Ben-Eliyahu, PhD
Tel Aviv, Isreal
- Erica Sloan, PhD
- Mike Grocott, MB,BS; FRCA
University of Southampton, UK
- Sushma Bhatnagar, MB,BS; MD
New Delhi, India
- Gregory Fischer, MD
New York, USA
- Miao Changhong, MD, PhD
- Jigi Divatia, MB,BS; MD
- Robert Schier, MD PhD